Evidence map›Paper›PMID 34278204›Full record

ArticleFrontiers in research metrics and analytics2021

Representing a Heterogeneous Pharmaceutical Knowledge-Graph with Textual Information.

Masaki Asada, Nallappan Gunasekaran, Makoto Miwa, Yutaka Sasaki

Abstract read
In one paragraph

Article in Frontiers in research metrics and analytics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Responsible models and indicators: challenges from artificial intelligence.Frontiers in research metrics and analytics · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Masaki AsadaComputational Intelligence Laboratory, Toyota Technological Institute, Nagoya, Japan.
Nallappan GunasekaranComputational Intelligence Laboratory, Toyota Technological Institute, Nagoya, Japan.
Makoto MiwaComputational Intelligence Laboratory, Toyota Technological Institute, Nagoya, Japan.
Yutaka SasakiComputational Intelligence Laboratory, Toyota Technological Institute, Nagoya, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We deal with a heterogeneous pharmaceutical knowledge-graph containing textual information built from several databases. The knowledge graph is a heterogeneous graph that includes a wide variety of concepts and attributes, some of which are provided in the form of textual pieces of information which have not been targeted in the conventional graph completion tasks. To investigate the utility of textual information for knowledge graph completion, we generate embeddings from textual descriptions given to heterogeneous items, such as drugs and proteins, while learning knowledge graph embeddings. We evaluate the obtained graph embeddings on the link prediction task for knowledge graph completion, which can be used for drug discovery and repurposing. We also compare the results with existing methods and discuss the utility of the textual information.

Indexed as

drug databaseheterogeneous networksknowledge graph completionknowledge graph embeddingtextual information

Identifiers

PMID34278204
PMCPMC8281808

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.